Literature DB >> 7451626

Rapid quantitative determination of underivatized carbamazepine, phenytoin, phenobarbital and p-hydroxyphenobarbital in biological fluids by packed column gas chromatography.

R Riva, F Albani, A Baruzzi.   

Abstract

A method is described for measuring, without derivatization, the concentrations of phenobarbital, p-hydroxyphenobarbital, carbamazepine and phenytoin in biological fluids of epileptic patients undergoing long-term therapy. This method uses, at an isothermal temperature, a special column packing (GP-2% SP-2510-DA on 100-120 mesh Supelcoport). The lower limit of detection for all substances analyzed is 1 microgram/ml of biological material. The recovery of the compounds is about 95%, the reproducibility of the method is good (coefficient of variation, 4.3%). The mass spectra confirm the identity of substances eluting from the column. There is no interference from other commonly used antiepileptic drugs or endogenous substances. The method has the advantages of high specificity, sensitivity and rapidity and it appears to be suitable for the routine monitoring of blood and urine concentrations in patients receiving multi-drug therapy.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 7451626     DOI: 10.1016/s0378-4347(00)81009-9

Source DB:  PubMed          Journal:  J Chromatogr


  3 in total

1.  Lack of relationship between sodium valproate-induced adverse effects and the plasma concentration of its metabolite 2-propylpenten-4-oic acid.

Authors:  M Paganini; G Zaccara; F Moroni; R Campostrini; L Bendoni; G Arnetoli; R Zappoli
Journal:  Eur J Clin Pharmacol       Date:  1987       Impact factor: 2.953

2.  Phenytoin-induced increase in growth hormone response to levodopa in adult males.

Authors:  R D'Alessandro; P Cortelli; R Gallassi; E Ghisoli; N Montanaro; E Zoni; A Baruzzi
Journal:  J Neurol Neurosurg Psychiatry       Date:  1984-07       Impact factor: 10.154

3.  Comparative kinetics of phenobarbital after administration of the acid and the propylhexedrine salt (barbexaclone).

Authors:  E Perucca; R Grimaldi; G Ruberto; C Gelmi; F Trimarchi; A Crema
Journal:  Eur J Clin Pharmacol       Date:  1986       Impact factor: 2.953

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.